Miri Halperin Wernli
Co-Founder and Group CEO
- Creso Pharma
Professional Information
Miri
Halperin Wernli
Co-Founder and Group CEO
Creso Pharma
Education, Honors & Awards
PhD, Genetics
Personal Information
Switzerland
Reading
Exercising
Music
More than 25 years
Miri Halperin Wernli has more than 35 years of professional experience in her field. Miri is now working out of Switzerland as a Co-Founder and Group CEO with Creso Pharma, where she has been for the last 3 years. Creso was created to bring pharmaceutical expertise and methodological rigor to the world of cannabis and deliver quality products to people and animals everywhere. Founded by a team of highly-experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialize innovative cannabis and hemp derived products. Miri works globally with Australia, Colombia, Israel, and Canada to develop products and commercialize.
Miri holds her PhD in Genetics. In the next few years, she plans to continue to grow, continue to develop and continue to make a difference in her field. She hopes to network as much as possible with likeminded professionals worldwide.
In her spare time, Miri enjoys reading, exercising and music.
Product Development
Websites & Social